← Eichor
Study identifier: NCT07584174 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Effects of Extracorporeal Shockwave Therapy Versus Pulsed Electromagnetic Field Therapy in Females With Sexual Dysfunction.

Condition: Female Sexual Dysfunction (FSD) · Pelvic Floor Muscle Training · Shock Wave  ·  Sponsor: Benha University

PhaseNA
Planned participants90
Who can joinFemale, 20 Years to 50 Years
Healthy volunteersNo

About this study

This is a prospective, three-arm, parallel-group, assessor-blinded randomized controlled trial designed to compare the effectiveness of extracorporeal shockwave therapy (ESWT) combined with pelvic floor muscle training (PFMT), pulsed electromagnetic field stimulation (PEMF) combined with PFMT, and PFMT alone in Females with sexual dysfunction. Participants will be randomly allocated in a 1:1:1 ratio, and the study duration is 16 weeks, including an 8-week intervention period and an 8-week follow-up period.

This description comes directly from the study's public registry record.

Talk to the study team

Mahmoud Hamada Mohamed Associate Professor, Ph.D  ·  01096968910  ·  mahmoud.mohamed@fpt.bu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Outpatient clinic, faculty of Physical Therapy, Beni Suef UniversityBanī Suwayf, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07584174